|
Monday, 03 November 2008 16:30 |
|
The Food and Drug Administration has approved new uses for the antidepressant Prozac (fluoxetine) to treat children and adolescents seven to 17 years of age for depression (major depressive disorder) and obsessive compulsive disorder (OCD). This is the first approval of one of the newer types of antidepressants (selective serotonin reuptake inhibitors or SSRIs) for treating depression in this population.
FDA Talk Papers FDA Approves Prozac for Pediatric Use to Treat Depression and OCD January 3, 2003
|
Wellness Research 
